Open Access. Powered by Scholars. Published by Universities.®

Medicine and Health Sciences Commons

Open Access. Powered by Scholars. Published by Universities.®

Physician Assistant Scholarly Project Posters

Book Gallery

Anxiety

Publication Year

Articles 1 - 5 of 5

Full-Text Articles in Medicine and Health Sciences

Ssri/Snri Medication Vs. Cognitive Behavioral Therapy In The Treatment And Management Of Postpartum Anxiety, Kelsey Sederquest Apr 2024

Ssri/Snri Medication Vs. Cognitive Behavioral Therapy In The Treatment And Management Of Postpartum Anxiety, Kelsey Sederquest

Physician Assistant Scholarly Project Posters

The purpose of this literature review is to determine the effects of cognitive behavioral therapy (CBT) and Selective Serotonin Reuptake Inhibitors/Selective Norepinephrine Reuptake Inhibitors (SSRI/SNRI) in women suffering from postpartum anxiety. Efficacy of non-pharmacological, pharmacological, and combination therapy compared within this review. Lastly, prophylactic treatment of anxiety was examined in women who were pregnant or who were newly postpartum without diagnosis of anxiety. In this review the database PubMed was utilized to conduct research that included many different keywords. The articles included were limited to within the last 30 years, and research was narrowed by limiting patient population to postpartum …


The Gut-Brain Axis: Treating Depression Through Microbiome Alterations, Alexandria Bachman-Williams Jan 2020

The Gut-Brain Axis: Treating Depression Through Microbiome Alterations, Alexandria Bachman-Williams

Physician Assistant Scholarly Project Posters

• The purpose of this study is to explore the role of gut microbiome alterations in the treatment of anxiety and depression. • There are multiple pathological pathways that lead to the development of anxiety and depression. • Research shows a link between pathologic bacteria and low grade inflammation. This causes a disruption of neurotransmitters that are current targets of pharmacological treatment of depression and anxiety. • Transfer of “pathogenic” bacteria caused increased symptoms of anxiety and depression. • Treatment with probiotics and “protective” bacteria showed decreased BDI scores and improved symptoms. • Studies were small but show need for …


Analysis Of Tech-Based And Telemental Health Approaches Within The Adolescent And Young Adult Populations Of Rural America, Audrey K. Smeenk Jan 2020

Analysis Of Tech-Based And Telemental Health Approaches Within The Adolescent And Young Adult Populations Of Rural America, Audrey K. Smeenk

Physician Assistant Scholarly Project Posters

The incidences of depression and anxiety among adolescent and young adult populations are intensifying, and resources remain limited for the management of these diseases within rural America.

• Evaluation on different interventions was completed to assess ease of access, efficacy, and patient adherence with the hope to decrease incidence of disease and increase availability of resources to rural areas.

• Based on the current completed research, there is a predominance of evidence that has shown moderate statistical data and promising outcomes from tech-based mobile applications and telemental health. Statistical evidence supports that technological based interventions are a potential treatment option …


Use Of Marijuana In Those With Anxiety And Depression, Heather Flaa Jan 2020

Use Of Marijuana In Those With Anxiety And Depression, Heather Flaa

Physician Assistant Scholarly Project Posters

The purpose of this research and literature review was to compare the use of marijuana to SSRIs in reducing anxiety and depression symptoms.

• This literature review searched databases Cochrane, PubMed, Clinical Key, PsycINFO, and DynaMed Plus from the year 1990 and on. Keywords: cannabis, marijuana, anxiety, generalized anxiety disorder, depression, and selective serotonin reuptake inhibitors.

• Many meta-analyses show SSRIs continue to be first line treatment in those with anxiety and depression in reducing symptoms.

• Patients with marijuana use showed an increased odds ratio of developing anxiety and depression or increasing symptoms in several studies.

• No studies …


Managing Anxiety With Pharmacogenomic Testing, Ashley Pommer Jan 2019

Managing Anxiety With Pharmacogenomic Testing, Ashley Pommer

Physician Assistant Scholarly Project Posters

Anxiety affects approximately three to seven percent of the United States population, and nearly 50% of the diagnosed patients fail to respond to first line treatment regimens (Boland, Duffy, & Meyer 2018). Traditional first line treatments include medication therapy, cognitive behavioral therapy (CBT), or the combination of both. With such a high initial failure rate, recent studies indicate promising results in managing anxiety with pharmacogenomic testing. Pharmacogenomic testing is allowing providers to prescribe medication based on individual genetic makeup, focusing on how each patient metabolizes certain medications. The purpose of this literature review was to determine if first line methods …